A Study of LNK01001 Capsule in Subjects With Active Rheumatoid Arthritis (COURAGE-RA)
Clinical trial NCT06276998 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06276998
- Sponsor
- Lynk Pharmaceuticals Co., Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-12
- Primary completion
- 2025-08-22
- Enrollment
- 430
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.